Sionna Therapeutics
0 followers
‌
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Industries
+2
Headquarters
Employees
Links
Org chart
Mike Cloonan
President & CEO
Mike Cloonan
Collapse
Mark Munson
Co-Founder & VP, Medicinal Chemistry
Greg Hurlbut
Co-Founder & SVP, Discovery Research
Elena Ridloff
CFO & Head of Corporate Development
Charlotte McKee
Chief Medical Officer
Mara Furlow
VP, Global Regulatory Affairs
Michael Hewitt
VP, Chemistry, Manufacturing & Controls
Heather Wolff
VP, Development Operations
Vanya Sagar
Chief People Officer
Andy Chu
VP, Information & Technology
Meghan Bagshaw
VP, Programs, Portfolio & Operations
Alison Easter
VP, Preclinical Safety
Maria D. Ribadeneira
VP, DMPK
Mark M.
Co-founder And Vice President Of Medicinal Chemistry At Sionna Therapeutics
Junkai Liao
Director
Scott Bercury
Principal Scientist
Steve Altmann
Principal Scientist
